Secondary Hemophagocytic Syndrome in a Patient with Plasma Cell Myeloma and CNS Involvement Treated with Lenalidomide

We present an extremely rare case report of a 29-year-old multiple myeloma patient with central nervous system involvement and secondary hemophagocytic lymphohistiocytosis (HLH). We observed that HLH was presumably triggered by the immunomodulatory drug—lenalidomide. HLH is frequently misdiagnosed o...

Descripción completa

Detalles Bibliográficos
Autores principales: Milczarek, Sławomir, Kulig, Piotr, Baumert, Bartłomiej, Łanocha, Aleksandra, Sommerfeld, Krzysztof, Borowiecka, Ewa, Osękowska, Bogumiła, Paczkowska, Edyta, Zdziarska, Barbara, Machaliński, Bogusław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606933/
https://www.ncbi.nlm.nih.gov/pubmed/36295511
http://dx.doi.org/10.3390/medicina58101350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606933/
https://www.ncbi.nlm.nih.gov/pubmed/36295511
http://dx.doi.org/10.3390/medicina58101350

Ejemplares similares